NFE2L2 and type 2 diabetes mellitus: In line with this, in type 2 diabetes, the low levels of CPT1A and acetyl-CoA carboxylase (ACC) were rescued by sulforaphane (SFN), a potent Nrf2 activator, suggesting that Nrf2 reduction decreases the levels of these proteins [55].